Drug insight: testosterone preparations (Q36675085)

15 August 2017

1 reference

title

Drug insight: testosterone preparations (English)

1 reference

15 August 2017

1 reference

1 reference

Upendram Srinivas-Shankar

series ordinal

1

1 reference

PubMed ID

17149382

15 August 2017

Frederick C W Wu

series ordinal

2

1 reference

PubMed ID

17149382

15 August 2017

language of work or name

English

0 references

publication date

1 December 2006

1 reference

15 August 2017

Nature Reviews Urology

1 reference

15 August 2017

3

1 reference

15 August 2017

12

1 reference

15 August 2017

653-665

1 reference

https://scigraph.springernature.com/pub.10.1038/ncpuro0650

15 August 2017

0 references

cites work

Oral testosterone supplementation increases muscle and decreases fat mass in healthy elderly males with low-normal gonadal status

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0650

Oral testosterone in oil plus dutasteride in men: a pharmacokinetic study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0650

7 January 2021

The CAG repeat polymorphism in the androgen receptor gene affects bone density and bone metabolism in healthy males

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0650

7 January 2021

The CAG repeat polymorphism in the AR gene affects high density lipoprotein cholesterol and arterial vasoreactivity

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0650

7 January 2021

Androgens rapidly increase the cytosolic calcium concentration in Sertoli cells

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0650

7 January 2021

Androgen-stimulated DNA synthesis and cytoskeletal changes in fibroblasts by a nontranscriptional receptor action

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0650

7 January 2021

A rapid, nongenomic, signaling pathway regulates the actin reorganization induced by activation of membrane testosterone receptors

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0650

7 January 2021

Pharmacokinetics and pharmacodynamics of subcutaneous testosterone implants in hypogonadal men.

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0650

7 January 2021

Testosterone release rate and duration of action of testosterone pellet implants

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0650

7 January 2021

Pharmacokinetics and pharmacodynamics of testosterone pellets in man

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0650

7 January 2021

Extrusion of testosterone pellets: a randomized controlled clinical study

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0650

7 January 2021

An analysis of testosterone implants for androgen replacement therapy

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0650

7 January 2021

Influence of implantation site and track geometry on the extrusion rate and pharmacology of testosterone implants

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0650

7 January 2021

Effects of testosterone enanthate in normal men: experience from a multicenter contraceptive efficacy study. World Health Organization Task Force on Methods for the Regulation of Male Fertility.

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0650

7 January 2021

Treatment of male hypogonadism with testosterone enanthate

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0650

7 January 2021

Bioavailability and LH-suppressing effect of different testosterone preparations in normal and hypogonadal men

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0650

7 January 2021

Testosterone therapy in adult men with androgen deficiency syndromes: an endocrine society clinical practice guideline

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0650

7 January 2021

Comparison of testosterone, dihydrotestosterone, luteinizing hormone, and follicle-stimulating hormone in serum after injection of testosterone enanthate of testosterone cypionate

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0650

7 January 2021

Hormone kinetics after intramuscular testosterone cypionate

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0650

7 January 2021

Comparative pharmacokinetics of testosterone enanthate and testosterone cyclohexanecarboxylate as assessed by serum and salivary testosterone levels in normal men

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0650

7 January 2021

Effects of depot testosterone therapy on serum levels of luteinizing hormone and follicle-stimulating hormone in patients with Klinefelter's syndrome and hypogonadotropic eunuchoidism

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0650

7 January 2021

Effects of Androgen on Sexual Behavior in Hypogonadal Men

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0650

7 January 2021

Testosterone replacement in hypogonadal men: effects on obstructive sleep apnoea, respiratory drives, and sleep

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0650

7 January 2021

The short-term effects of high-dose testosterone on sleep, breathing, and function in older men.

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0650

7 January 2021

Testosterone replacement in older hypogonadal men: a 12-month randomized controlled trial.

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0650

7 January 2021

Tolerability of intramuscular injections of testosterone ester in oil vehicle

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0650

7 January 2021

Intramuscular injection of testosterone undecanoate for the treatment of male hypogonadism: phase I studies

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0650

7 January 2021

Intramuscular testosterone undecanoate: pharmacokinetic aspects of a novel testosterone formulation during long-term treatment of men with hypogonadism

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0650

7 January 2021

Testosterone release from a subcutaneous, biodegradable microcapsule formulation (Viatrel) in hypogonadal men.

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0650

7 January 2021

Which testosterone replacement therapy?

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0650

7 January 2021

Effect of long-term oral testosterone undecanoate treatment on prostate volume and serum prostate-specific antigen concentration in eugonadal middle-aged men

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0650

7 January 2021

Randomized clinical trial of testosterone replacement therapy in hypogonadal men

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0650

7 January 2021

Effect of 12 month oral testosterone on testosterone deficiency symptoms in symptomatic elderly males with low-normal gonadal status

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0650

7 January 2021

Oral testosterone undecanoate (Andriol) supplement therapy improves the quality of life for men with testosterone deficiency

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0650

7 January 2021

Androgen replacement with oral testosterone undecanoate in hypogonadal men: a double blind controlled study.

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0650

7 January 2021

Oral methyltestosterone and jaundice.

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0650

7 January 2021

Hepatotoxic effects of the anabolic/androgenic steroids

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0650

7 January 2021

Investigation, treatment and monitoring of late-onset hypogonadism in males

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0650

7 January 2021

Androgen treatment without inhibiting effect on hypophysis and male gonads. Biochemical and morphological studies after treatment with Mesterolone

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0650

7 January 2021

The effect of mesterolone administration to normal men on the pituitary-testicular function.

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0650

7 January 2021

Substitution therapy of hypogonadal men with transdermal testosterone over one year

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0650

7 January 2021

Transdermal testosterone substitution therapy for male hypogonadism

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0650

7 January 2021

Long-term substitution therapy of hypogonadal men with transscrotal testosterone over 7-10 years

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0650

7 January 2021

Transdermal delivery of testosterone

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0650

7 January 2021

Androgen therapy of hypogonadal men with transscrotal testosterone systems

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0650

7 January 2021

Androgen metabolism in human skin

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0650

7 January 2021

Long-term efficacy and safety of a permeation-enhanced testosterone transdermal system in hypogonadal men.

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0650

7 January 2021

Prostate size in hypogonadal men treated with a nonscrotal permeation-enhanced testosterone transdermal system

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0650

7 January 2021

Pharmacokinetics of a new transdermal testosterone gel in gonadotrophin-suppressed normal men.

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0650

7 January 2021

Long-term testosterone gel (AndroGel) treatment maintains beneficial effects on sexual function and mood, lean and fat mass, and bone mineral density in hypogonadal men.

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0650

7 January 2021

Three-year follow-up of androgen treatment in hypogonadal men: preliminary report with testosterone gel.

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0650

7 January 2021

Interpersonal testosterone transfer after topical application of a newly developed testosterone gel preparation

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0650

7 January 2021

A comparison of a novel testosterone bioadhesive buccal system, striant, with a testosterone adhesive patch in hypogonadal males

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0650

7 January 2021

New testosterone buccal system (Striant) delivers physiological testosterone levels: pharmacokinetics study in hypogonadal men.

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0650

7 January 2021

Short-term pharmacokinetic comparison of a novel testosterone buccal system and a testosterone gel in testosterone deficient men.

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0650

7 January 2021

A Clinical Trial of 7α-Methyl-19-Nortestosterone Implants for Possible Use as a Long-Acting Contraceptive for Men

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0650

7 January 2021

Evidence for tissue selectivity of the synthetic androgen 7 alpha-methyl-19-nortestosterone in hypogonadal men.

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0650

7 January 2021

Selective androgen receptor modulator treatment improves muscle strength and body composition and prevents bone loss in orchidectomized rats

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0650

7 January 2021

A selective androgen receptor modulator for hormonal male contraception

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0650

7 January 2021

7 Testicular steroidogenesis and androgen use and abuse

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0650

7 January 2021

Identifiers

DOI

10.1038/NCPURO0650

1 reference

15 August 2017

1 reference

PubMed ID

17149382